.png?sfvrsn=146b5c1b_2)
Creating pathways to biosimilars
As a pioneer in oncology biosimilars, we’re transforming access to affordable therapies through innovation, development, and partnerships. With continued investment and an expanding portfolio in new therapeutic areas, we’re breaking barriers to care—delivering high-quality, effective treatments without compromise.
- 1&2 top selling biosimilars in Canada
- #1 oncology patient support program